2-amino-2-methyl-1-propanol has been researched along with Fatty Liver in 1 studies
*Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bates, C; Garnick, L; Maier, A; Massarsky, A; Monnot, AD; Spencer, P; Sura, P | 1 |
1 review(s) available for 2-amino-2-methyl-1-propanol and Fatty Liver
| Article | Year |
|---|---|
Dose and exposure route analyses inform relationships between liver steatosis and 2-amino-2-methyl-1-propanol: Implications for hazard characterization.
Topics: Adenosine Monophosphate; Animals; Chemical and Drug Induced Liver Injury; Choline; Fatty Liver; Humans | 2022 |